Gedske Daugaard
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 166 publications
Alkaline Phosphatase and Prostate-specific Antigen Response in Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide Alone or in Combination with Radium-223: Ad Hoc Analysis of the PEACE-3 Consortium Trial.
Journal: European urology oncology
Published: March 17, 2026
International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions: Working Group 4 Precursor Lesions of Testis Results of a Premeeting Survey.
Journal: The American journal of surgical pathology
Published: February 22, 2026
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 04, 2026
Second edition ICCR dataset for testicular germ cell tumours: a reporting guide for histopathological diagnosis of orchiectomy specimens.
Journal: Histopathology
Published: December 12, 2025
A Unified Machine Learning Model for Relapse Prediction in Clinical Stage I Testicular Cancer.
Journal: Andrology
Published: September 30, 2025
Risk of childhood and adolescent, and young adult cancer in offspring of men with testicular cancer: A Danish nationwide study.
Journal: International journal of cancer
Published: September 05, 2025
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.
Journal: Nature communications
Published: July 25, 2025
A simple plan: chemotherapy-sparing approaches to early-stage and regional seminoma and nonseminoma.
A simple plan: chemotherapy-sparing approaches to early-stage and regional seminoma and nonseminoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 30, 2025
Vibostolimab Coformulated with Pembrolizumab in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: KEYNOTE-365 Cohort G.
Journal: European urology focus
Published: April 17, 2025
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 12, 2025
Parallel Phase II Clinical Trials of Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma.
Journal: JTO clinical and research reports
Published: January 27, 2025
Last Updated: 09/26/2026